Central and Peripheral Energy Regulation (CAPER)
Research type
Research Study
Full title
Pancreatic dopamine signalling and striatal activation in response to glucose in health and mental disorders
IRAS ID
275528
Contact name
Oliver Howes
Contact email
Sponsor organisation
Joint Research Compliance Office, Imperial College London
Duration of Study in the UK
5 years, 0 months, 1 days
Research summary
Alterations in glucose metabolism and dopamine signalling outside the brain have been proposed in the pathophysiology of schizophrenia but have yet to be demonstrated in vivo in humans. We propose to use imaging of the brain and pancreas to assess for differences in energy regulation between healthy controls and patients with schizophrenia. The study will employ Positron Emission Tomography (PET) to image dopamine signalling within the pancreas, using [11C]-(+)-propylhexahydronaphthooxazinol ([11C]PHNO), a radiotracer that binds to D2 and D3 dopamine receptors. It will employ functional magnetic resonance imaging (fMRI) to assess brain activity, specifically striatal activation, when exposed to food and non-food cues. Differences in pancreatic dopamine signalling and striatal functional activation in patients and controls will be assessed before and after a glucose challenge.
REC name
West Midlands - South Birmingham Research Ethics Committee
REC reference
21/WM/0014
Date of REC Opinion
2 Mar 2021
REC opinion
Further Information Favourable Opinion